Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal Bleeding
- 31 July 2009
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 137 (1), 119-128
- https://doi.org/10.1053/j.gastro.2009.03.048
Abstract
No abstract availableFunding Information
- Agència de Gestió d'Ajuts Universitaris i de Recerca (SGR05)
- Instituto de Salud Carlos III (CO3/02)
This publication has 30 references indexed in Scilit:
- Portal hypertension and variceal bleeding-Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conferenceHepatology, 2008
- How to Prevent Varices From Bleeding: Shades of Grey—The Case for Nonselective β BlockersGastroenterology, 2007
- Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic ReviewGastroenterology, 2006
- Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosisJournal of Hepatology, 2004
- The hepatic venous pressure gradient: Anything worth doing should be done rightHepatology, 2004
- Targeting portal pressure measurements: A critical reappraisalHepatology, 2004
- Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosisHepatology, 2003
- Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical studyAlimentary Pharmacology & Therapeutics, 2002
- Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal RebleedingThe New England Journal of Medicine, 1996
- Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosisThe Lancet, 1995